Primary Investigator:
Chris Zylak, MD

Description:
The SAMMPRIS trial is being done to determine whether intracranial stenting (a device inserted in a blood vessel in the brain) combined with intensive medical therapy is better than intensive medical therapy alone for preventing stroke or death in individuals who have had a stroke or TIA (mini stroke) caused by a narrowing in one of the arteries in the brain.

Eligibility:

• Between the ages of 30 and 80 years
• Have had a stroke or TIA (mini-stroke) within 30 days
• Have stenosis (narrowing) of a major intracranial artery (blood vessel in the brain).
• Other inclusion criteria may apply. Please contact study coordinator.

Exclusions:

• Narrowing in any artery in the head or neck that has been treated within the past 30 days.
• Other exclusions apply. Please contact study coordinator

Study Timeline:
Closed to enrollment

Study Contact:

Ruthie RN, CCRC  Ruth.Franks@providence.org

 

Study Sponsor:
National Institutes of Health/ Boston Scientific